Chemed Corp (CHE) News

Chemed Corp (CHE): $468.39

-1.64 (-0.35%)

POWR Rating

Component Grades













Filter CHE News Items

CHE News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CHE News Highlights

  • CHE's 30 day story count now stands at 3.
  • Over the past 26 days, the trend for CHE's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest CHE News From Around the Web

Below are the latest news stories about Chemed Corp that investors may wish to consider to help them evaluate CHE as an investment opportunity.

Here's Why Chemed (CHE) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | September 21, 2021

Chemed (CHE) Moves to Buy: Rationale Behind the Upgrade

Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Yahoo | September 17, 2021

Chemed (CHE) Up 1.9% Since Last Earnings Report: Can It Continue?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | August 26, 2021

Chemed (CHE) Upgraded to Buy: Here's Why

Chemed (CHE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | August 17, 2021

Here's Why You Should Add Chemed (CHE) to Your Portfolio Now

Investors are optimistic about Chemed (CHE) on strong segmental growth and raised Roto-Rooter and earnings guidance for 2021.

Yahoo | August 12, 2021

Chemed Corporation Declares Quarterly Dividend of 36 Cents

CINCINNATI, August 06, 2021--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company’s capital stock, payable on September 2, 2021, to shareholders of record as of August 16, 2021. This is a 2-cent, or 5.9%, increase over the 34-cent dividend paid in June 2021. The previous dividend increase was in August 2020, when the Board raised the quarterly dividend from 32-cents to 34-cents per share. This repres

Yahoo | August 6, 2021

DaVita (DVA) Beats on Q2 Earnings, Raises 2021 EPS View

DaVita's (DVA) strength in dialysis patient service revenues drives its Q2 top line.

Yahoo | August 4, 2021

PacBio's (PACB) Q2 Earnings Miss Estimates, Revenues Top

PacBio (PACB) sees strength in Q2 product revenues, led by robust consumable sales.

Yahoo | August 4, 2021

CVS Health (CVS) Q2 Earnings Beat Estimates, EPS View Up

CVS Health (CVS) Q2 adjusted EPS drops year over year on escalating costs and expenses which are putting pressure on margins.

Yahoo | August 4, 2021

Avanos Medical (AVNS) Q2 Earnings Lag Estimates, Revenues Top

Avanos Medical's (AVNS) second-quarter 2021 results gains from strength in Pain Management segment.

Yahoo | August 4, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7037 seconds.